Previous 10 | Next 10 |
2023-05-10 23:50:25 ET Organogenesis Holdings Inc. (ORGO) Q1 2023 Earnings Conference Call May 10, 2023 05:00 PM ET Company Participants Gary Gillheeney - President and CEO Dave Francisco - CFO Conference Call Participants Ryan Zimmerman - BTIG Pres...
2023-05-10 16:37:45 ET Organogenesis Holdings press release ( NASDAQ: ORGO ): Q1 GAAP EPS of -$0.02. Revenue of $107.6M (+10.8% Y/Y). Sees FY 2023 net revenue between $454 million and $466 million. ORGO had guided FY 2023 revenue of $450M and $462M. ...
CANTON, Mass., May 10, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today rep...
2023-04-27 07:44:33 ET Organogenesis ( NASDAQ: ORGO ) Board of Directors has elected President and CEO Gary S. Gillheeney, Sr., as Chair of the Board, effective immediately. Gillheeney will continue in his role as President and CEO, which he has held since 2014. Mr. Gi...
CANTON, Mass., April 27, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today ann...
CANTON, Mass., April 10, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today ann...
CANTON, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, applauds ...
2023-03-06 18:29:09 ET Shares of Unisys (NYSE: UIS) , Organogenesis Holdings (NASDAQ: ORGO) , and Motorcar Parts of America (NASDAQ: MPAA) fell today as all three stocks were removed from the S&P SmallCap 600 index as part of its quarterly rebalancing. Th...
Fair Isaac & Co. Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 Fair Isaac & Co. Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 PR Newswire NEW YORK , March 3, 2023 /PRNewswire/...
Organogenesis Holdings ( NASDAQ: ORGO ) has reported favorable outcome of the interim analysis of its Phase 3 trial of ReNu, a cryopreserved amniotic suspension allograft (ASA) for management of symptoms associated with knee osteoarthritis. The pre-specified interim analysis on 50...
News, Short Squeeze, Breakout and More Instantly...
Organogenesis Holdings Inc. Company Name:
ORGO Stock Symbol:
NASDAQ Market:
Organogenesis Holdings Inc. Website:
CANTON, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...
2024-06-28 10:00:07 ET Brooks O'Neil from Lake Street issued a price target of $5.00 for ORGO on 2024-06-28 08:01:00. The adjusted price target was set to $5.00. At the time of the announcement, ORGO was trading at $2.64. ORGO currently trades -43.21% versus its 52 week ...
CANTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today an...